PIK3CA and neoplasm: This extended panel contains genetic variations that may lead to activation of the MAPK/MET/PI3K-AKT pathways or protooncogenes, as well as compromise the tumor suppressor function, based on a number of recent discoveries, including those reported by the National Cancer Genome Atlas Research Network in thyroid cancer cases [4].